https://www.selleckchem.com/pr....oducts/8-cyclopentyl
6 to 29.1 points), also, the power of the lower limbs increased. There were no bleeding episodes during the intervention and after a 3-month follow-up. The proposed program during the application of the new prophylactic treatment seems to be effective in improving quality of life and increasing lower limb power in a hemophilic patient with an inhibitor. However, randomized clinical trials are needed to confirm the results. The proposed program during the application of the new prophylactic treatment seems to b
Like
Comment
Share
